MedPath

PFIZER INC.

PFIZER INC. logo
🇺🇸United States
Ownership
Public
Established
1849-01-01
Employees
88K
Market Cap
$163.3B
Website
http://www.pfizer.com

Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)

Phase 1
Completed
Conditions
Juvenile Idiopathic Arthritis
Interventions
First Posted Date
2012-01-20
Last Posted Date
2016-07-04
Lead Sponsor
Pfizer
Target Recruit Count
26
Registration Number
NCT01513902
Locations
🇵🇱

Klinika Kardiologii i Reumatologii Dzieciecej, Lodz, Poland

🇩🇪

PRI - Pediatric Rheumatology Research Institute GmbH, Bad Bramstedt, Germany

🇩🇪

Hamburger Zentrum fuer Kinder-und Jugendrheumatologie SchoenKlinik Hamburg Eilbek, Hamburg, Germany

and more 7 locations

Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain

Phase 2
Terminated
Conditions
Post-surgical Dental Pain
Interventions
First Posted Date
2012-01-19
Last Posted Date
2013-06-28
Lead Sponsor
Pfizer
Target Recruit Count
90
Registration Number
NCT01512160
Locations
🇺🇸

Pfizer Investigational Site, Austin, Texas, United States

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers

Phase 1
Completed
Conditions
Pain
Migraine Disorders
Interventions
Biological: PF-04427429
Other: Normal saline
First Posted Date
2012-01-18
Last Posted Date
2013-02-21
Lead Sponsor
Pfizer
Target Recruit Count
31
Registration Number
NCT01511497
Locations
🇺🇸

Pfizer Investigational Site, Dallas, Texas, United States

Prevenar13 Post Market Surveillance

Completed
Conditions
Healthy
Interventions
Biological: 13-valent pneumococcal vaccine
First Posted Date
2012-01-12
Last Posted Date
2017-02-13
Lead Sponsor
Pfizer
Target Recruit Count
649
Registration Number
NCT01509105
Locations
🇰🇷

Choi's Pediatric Clinic, Wonju-si, Gangwon-do, Korea, Republic of

🇰🇷

Seoul Children's Hospital, Osan, Gyeonggi-do, Korea, Republic of

🇰🇷

Teun Teun Pediatric clinic, Suwon-si, Gyeonggi-do, Korea, Republic of

and more 15 locations

Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

Phase 2
Completed
Conditions
Juvenile Idiopathic Arthritis
Interventions
First Posted Date
2011-12-28
Last Posted Date
2025-05-06
Lead Sponsor
Pfizer
Target Recruit Count
302
Registration Number
NCT01500551
Locations
🇺🇦

Communal Non-profit Enterprise, Vinnytsia, Ukraine

🇮🇳

Sir Ganga Ram Hospital, New Delhi, India

🇮🇱

Rambam Health Care Campus, Haifa, Israel

and more 100 locations

A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase (ALK) Positive Advanced Non-Small Cell Lung Cancer

Phase 2
Withdrawn
Conditions
Non-Small Cell Lung Cancer
Interventions
First Posted Date
2011-12-28
Last Posted Date
2013-02-25
Lead Sponsor
Pfizer
Registration Number
NCT01500824

Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections

Phase 3
Completed
Conditions
Complicated Intra-Abdominal Infection
Interventions
First Posted Date
2011-12-26
Last Posted Date
2017-09-06
Lead Sponsor
Pfizer
Target Recruit Count
493
Registration Number
NCT01499290
Locations
🇺🇦

Research Site, Zaporizhzhya, Ukraine

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

Phase 3
Completed
Conditions
Complicated Skin and Soft Tissue Infection
Interventions
First Posted Date
2011-12-26
Last Posted Date
2017-09-06
Lead Sponsor
Pfizer
Target Recruit Count
802
Registration Number
NCT01499277
Locations
🇺🇦

Research Site, Odesa, Ukraine

A Single Dose Study Of PF-06291874 In Healthy Adult Subjects

Phase 1
Terminated
Conditions
Healthy
Interventions
First Posted Date
2011-12-26
Last Posted Date
2012-01-31
Lead Sponsor
Pfizer
Target Recruit Count
9
Registration Number
NCT01499017
Locations
🇺🇸

Pfizer Investigational Site, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath